Back
Teva Pharmaceutical Industries Vs. Can Fite Biofarma Industry Stock Comparison
Buy
57
TEVA
Teva Pharmaceutical Industries
Last Price:
18.78
Seasonality Move:
12.65%
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.15
Seasonality Move:
-3.85%
Buy
57
Teva Pharmaceutical Industries (TEVA)
is a Buy
Is Teva Pharmaceutical Industries a Buy, Sell or Hold?
- The current Teva Pharmaceutical Industries [TEVA] share price is $18.64. The Score for TEVA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- TEVA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $2.15. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TEVA Stock Price Chart
What is Teva Pharmaceutical Industries's stock price today?
-
The Teva Pharmaceutical Industries share price today is $18.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TEVA is experiencing slight buying pressure.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $2.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.
TEVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 60.4 | Buy |
| Chaikin Money Flow: | 1688537 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.48 - 18.4) | Buy |
| Bollinger Bands (100): | (16.77 - 18.27) | Buy |
CANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 39.41 | Sell |
| Chaikin Money Flow: | -97705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.04 - 2.66) | Sell |
| Bollinger Bands (100): | (2.1 - 3.16) | Sell |
TEVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.38 | Buy |
| 20-day SMA: | 18.03 | Buy |
| 50-day SMA: | 18.03 | Buy |
| 200-day SMA: | 15.78 | Buy |
| 8-day EMA: | 18.41 | Buy |
| 20-day EMA: | 18.17 | Buy |
| 50-day EMA: | 17.9 | Buy |
| 200-day EMA: | 15.81 | Buy |
CANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.31 | Sell |
| 20-day SMA: | 2.44 | Sell |
| 50-day SMA: | 2.29 | Sell |
| 200-day SMA: | 2.4 | Sell |
| 8-day EMA: | 2.3 | Sell |
| 20-day EMA: | 2.36 | Sell |
| 50-day EMA: | 2.39 | Sell |
| 200-day EMA: | 2.51 | Sell |
Teva Pharmaceutical Industries Earnings Growth & TEVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.32 per share.
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
Teva Pharmaceutical Industries Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Can Fite Biofarma Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||